Douglas Murphy-Chutorian - Feb 22, 2022 Form 4 Insider Report for Semler Scientific, Inc. (SMLR)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Daniel E. Conger, Attorney-in-fact
Stock symbol
SMLR
Transactions as of
Feb 22, 2022
Transactions value $
-$136,230
Form type
4
Date filed
2/24/2022, 03:01 PM
Previous filing
Feb 16, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMLR Common Stock Options Exercise $4.2K +2K $2.10* 2K Feb 22, 2022 Direct
transaction SMLR Common Stock Sale -$72.5K -1.04K -51.9% $69.82 962 Feb 22, 2022 Direct F1, F2
transaction SMLR Common Stock Sale -$68K -962 -100% $70.64 0 Feb 22, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMLR Stock Option (right to buy) Options Exercise $0 -2K -2.67% $0.00 73K Feb 22, 2022 Common Stock 2K $2.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on December 7, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.30 to $70.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.34 to $71.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
F4 The shares underlying the option are fully vested and immediately exercisable.